I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Changchun Gaoxin (000661.SZ) announced that its subsidiary, Changchun JinSai Pharmaceutical Co., Ltd. ("JinSai Pharmaceutical"), received a written notice from the U.S. Food and Drug Administration ("FDA") that the clinical trial application for GenSci143 for injection has been accepted, with the indication being: advanced solid tumors
